Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2009 / Cilt: 10 - Sayı: 2

Intravenous immunglobulin therapy in a case with chronic bullous disease of childhood

Çocukluk çağının kronik büllöz hastalağı tanılı bir olguda intravenöz immunglobulin tedavisi

Pages
33–35
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Following the intravenous immunglobulin use for treatment, the skin lesions revealed rapid healingwithin three days.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic bullous disease of childhood, one of the subepidermal bullous diseases is uncommon, and its etiology has not fully understood.
📊
Key Findings & Data:A linear deposition of IgA at the epidermal basement membrane on direct immunoflorescence is pathognomonic for the disease.
💡
Conclusion & Impact:Following the intravenous immunglobulin use for treatment, the skin lesions revealed rapid healingwithin three days.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chronic bullous disease of childhood, one of the subepidermal bullous diseases is uncommon, and its etiology has not fully understood. A linear deposition of IgA at the epidermal basement membrane on direct immunoflorescence is pathognomonic for the disease. Dapson is commonly used in the therapy. Intravenous immunglobulin is a recent choice in the treatment. A twelve-months old boy was admitted to the hospital with the complaints of mutipl blisters on his face, especially perioral region, buttocks and extremities. Examination of the skin biopsy specimen with direct immunoflorescencemethod showed linear deposits of IgAalong the dermoepidermal junction. In the light of the findings, condition was diagnosed as chronic bullous disease of childhood. Following the intravenous immunglobulin use for treatment, the skin lesions revealed rapid healingwithin three days.

Özet

Çocukluk çağının kronik büllöz hastalığı nadir görülen, etiyolojisi tam olarak bilinmeyen subepidermal büllü hastalıklardandır. Bu hastalıkta direkt immunofloresan yöntemi ile epidermal bazal membranda IgA'nın lineer depolanması patognomoniktir. Tedavide sıkılıkla dapson kullanılır. İntravenöz immunglobulin tedavide yeni bir yaklaşımdır. Oniki aylık erkek hasta özellikle ağız çevresinde olmak üzere yüzünde, kalçasında, kol ve bacaklarında çok sayıda bül varlığı yakınması ile başvuru üzerine hastaneye yatırıldı. Cilt biyopsi örneğinin direkt immunofloresan yöntemiyle incelenmesinde dermoepidermal hat boyunca IgA depolandığı görüldü. Bu bulgularla olguya çocukluk çağı kronik büllöz hastalığı tanısı konuldu. Olguda tedavi amacıyla intravenöz immunglobulin kullanıldı ve üç gün içinde tüm lezyonların tamamen iyileştiği belirlendi. Hasta bir yıldır herhangibir tekrarlama görülmeksizin takip edilmektedir.

🔖

Cite This Article

APA, H., HIZARCIOĞLU, M., KAYSERİLİ, E., GÜLEZ, P., ORTAÇ, R., AFŞAR, Ş. (2022). Intravenous immunglobulin therapy in a case with chronic bullous disease of childhood. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 10 - Sayı: 2, 33–35. https://ajindex.com/articles/428987

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Powell JJ,Wojnarowska F. Chronic bullous disease of childhood: Linear IgAdisease of childhood and mixed immunobullous disease. In: Harper J, Oranje A, Prose N, eds. Textbook of pediatric dermatology 2nd ed. Blackwell Publishing,Massachusetts,2006:835-47
  2. Morelli JG. Linear IgA Dermatosis (Chronic Bullous Dermatosis of Childhood). In: Kliegman, Behrman, Jenson, Stanton eds.Nelson textbook of pediatrics 18th ed. Saunders, Philadelphia, 2007:2692-3
  3. Bayram N, Eşrefoğlu M. Otoimmün büllöz hastalıklarda güncel tedavi yaklaşımları. İnönü ÜniversitesiTıp FakültesiDergisi 2002;9:67-76
  4. Ang P, Tay YK. Treatment of linear IgA bullous dermatosis of childhood with colchicine. Pediatr Dermatol 1999;16:50-2
  5. Siegfried CE. Chronic bullous diseases of chidhood succesfull treatment with dicloxacilline. J Am Acad Dermatol 1998;39:797-800
  6. Cooper SM, Powell J, Wojnarowska F. Linear IgA disease: successful treatment with erythromycin. Clin ExpDermatol 2002; 27: 677-9
  7. Khan IU, Bhol KC, Ahmed AR. Linear immunglobuline A bullous dermatosis patient with chronic renal failure: response to intravenous immunglobuline therapy. J Am Acad Dermatol 1999;40:485-8
  8. Segura S, Iranzo P, Martínez-de Pablo I, Mascaró JM Jr, Alsina M, Herrero J, Herrero C. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. J Am Acad Dermatol 2007;56:960-7
  9. Waldman MA, Black DR, Callen JP. Vancomycin- induced linear IgA bullous disease presenting as toxic epidermal necrolysis.Clin ExpDermatol 2004;29:633-6
  10. Shimanovich I, Rose C, Sitaru C, Brocker EB, Zillikens D. Localized linear IgA disease induced by ampicillin/sulbactam. J Am Acad Dermatol 2004;51:95-8
  11. Cohen LM, Ugent RB. Linear IgA bullous dermatitis occuring after carbamazepine. J Am Acad Dermatol 2002;46:S32-3
  12. Avcı O, ÖkmenM, Çetiner S.Acetaminophen induced linear IgA bullous dermatosis. J Am Acad Dermatol 2003;48:299-301
  13. Ho JC,Ng PL,Tan SH,GiamYC.Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid. PediatrDermatol 2007;24:40-3
  14. Salmhofer W, Soyer HP, Wolf P, Fodinger D, Hodl S, Kerl H. UV light-induced linear IgA dermatosis. J Am Acad Dermatol 2004;50:109-15
  15. Powell J, Kirtcschig.Mixed Immunobullos diseases of childhood: A good response to antimicrobials. Br J Dermatol 2001;144:769-74
  16. Alajlan A,Al-Khawajah M,Al-SheikhO,Al-Saif F,Al- Rasheed S, Al-Hoqail I, Hamadah IR. Treatment of